Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study.

Kim SJ, Kim K, Kim BS, Kim CY, Suh C, Huh J, Lee SW, Kim JS, Cho J, Lee GW, Kang KM, Eom HS, Pyo HR, Ahn YC, Ko YH, Kim WS.

J Clin Oncol. 2009 Dec 10;27(35):6027-32. doi: 10.1200/JCO.2009.23.8592. Epub 2009 Nov 2.

PMID:
19884539
2.

Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatment.

Kohrt H, Advani R.

Leuk Lymphoma. 2009 Nov;50(11):1773-84. doi: 10.3109/10428190903186502. Review.

PMID:
19883307
3.

Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211.

Yamaguchi M, Tobinai K, Oguchi M, Ishizuka N, Kobayashi Y, Isobe Y, Ishizawa K, Maseki N, Itoh K, Usui N, Wasada I, Kinoshita T, Ohshima K, Matsuno Y, Terauchi T, Nawano S, Ishikura S, Kagami Y, Hotta T, Oshimi K.

J Clin Oncol. 2009 Nov 20;27(33):5594-600. doi: 10.1200/JCO.2009.23.8295. Epub 2009 Oct 5.

PMID:
19805668
4.

Unusual presentation of primary cardiac lymphoma.

Bagwan IN, Desai S, Wotherspoon A, Sheppard MN.

Interact Cardiovasc Thorac Surg. 2009 Jul;9(1):127-9. doi: 10.1510/icvts.2009.204628. Epub 2009 Apr 7.

PMID:
19351686
5.

Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project.

Au WY, Weisenburger DD, Intragumtornchai T, Nakamura S, Kim WS, Sng I, Vose J, Armitage JO, Liang R; International Peripheral T-Cell Lymphoma Project.

Blood. 2009 Apr 23;113(17):3931-7. doi: 10.1182/blood-2008-10-185256. Epub 2008 Nov 24.

6.

L-asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature.

Jaccard A, Petit B, Girault S, Suarez F, Gressin R, Zini JM, Coiteux V, Larroche C, Devidas A, Thiéblemont C, Gaulard P, Marin B, Gachard N, Bordessoule D, Hermine O.

Ann Oncol. 2009 Jan;20(1):110-6. doi: 10.1093/annonc/mdn542. Epub 2008 Aug 13. Review.

PMID:
18701429
7.

Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia.

Yamaguchi M, Suzuki R, Kwong YL, Kim WS, Hasegawa Y, Izutsu K, Suzumiya J, Okamura T, Nakamura S, Kawa K, Oshimi K.

Cancer Sci. 2008 May;99(5):1016-20. doi: 10.1111/j.1349-7006.2008.00768.x. Epub 2008 Feb 19.

8.

CMED in the treatment of nasal natural killer cell lymphoma with distant metastases.

Avilés A, Cleto S, Castañeda C, Nambo MJ.

Hematology. 2007 Jun;12(3):241-4.

PMID:
17558700
9.

Primary cardiac lymphoma: report of two cases occurring in immunocompetent subjects.

Anghel G, Zoli V, Petti N, Remotti D, Feccia M, Pino P, Majolino I.

Leuk Lymphoma. 2004 Apr;45(4):781-8. Review.

PMID:
15160956
10.

Natural killer cell neoplasms: a distinctive group of highly aggressive lymphomas/leukemias.

Cheung MM, Chan JK, Wong KF.

Semin Hematol. 2003 Jul;40(3):221-32. Review.

PMID:
12876671
11.

Primary neoplasms of the heart. Clinical and histological presentation of 50 cases.

Fernandes F, Soufen HN, Ianni BM, Arteaga E, Ramires FJ, Mady C.

Arq Bras Cardiol. 2001 Mar;76(3):231-7. English, Portuguese.

12.

Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells.

Yamaguchi M, Kita K, Miwa H, Nishii K, Oka K, Ohno T, Shirakawa S, Fukumoto M.

Cancer. 1995 Dec 1;76(11):2351-6.

13.

Tumors of the heart. A 20-year experience with a review of 12,485 consecutive autopsies.

Lam KY, Dickens P, Chan AC.

Arch Pathol Lab Med. 1993 Oct;117(10):1027-31.

PMID:
8215825

Supplemental Content

Support Center